X
XLinkedinWhatsAppTelegramTelegram
0
Read this article in:

European Union: EFSA - Sample-based data model extended to veterinary drug residues

EFSA is extending the use of its harmonised sample-based data reporting model to the collection of data on veterinary medicinal product residues in animals and animal products.

1 April 2015
X
XLinkedinWhatsAppTelegramTelegram
0

EFSA is extending the use of its harmonised sample-based data reporting model to the collection of data on veterinary medicinal product residues in animals and animal products.

Sample-based reporting using standardised description elements is already used to collect occurrence data from Member States in areas such as food additives, chemical contaminants, pesticide residues and antimicrobial resistance.

Monitoring data on veterinary medicinal product (VMP) residues are currently submitted annually in an aggregated format to a database maintained by the European Commission. EFSA then examines the data and presents the results in annual reports. However, aggregation does not lend itself to complex statistical analysis and is of limited value for quantitative exposure and risk assessments. The move to direct collection of data in a sample-based format will enable EFSA and the European Commission to tackle questions related to the risk assessment and risk management of VMP residues.

Tuesday March 31, 2015/ EFSA/ European Union.
http://www.efsa.europa.eu

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list pig333.com in 3 minutes

Weekly newsletter with all the pig333.com updates

Log in and sign up on the list

Related articles